As of 2025-10-27, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (2.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -425.6%.
The range of the Relative Valuation is (2.58) - (1.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 1.3x | 1.0x |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (2.58) - (1.59) | (2.28) |
| Upside | -469.0% - -327.9% | -425.6% |
| Date | P/E |